Abstract
The purpose of this study is to provide a brief overview of Alzheimer's disease and a definition of moderate disability that includes (MCI). This paper focuses on the medical and cardiovascular properties of Alzheimer's disease and Parkinson's. This article also covers the recent advances in the use of biomarkers to diagnose Alzheimer's disease, as well as existing efforts to find new therapies. Alzheimer's disease (AD), the most common form of dementia, affects 50 lakh Indians aged 65 and over, or one in nine. A Clinical and Research Science Review of Alzheimer's Disease. There has been significant progress in identifying pre-dementia stages of Alzheimer's disease, such as MCI, as well as developing diagnosis and therapeutic procedures for treating Alzheimer's disease. Our ability to find a cure for Alzheimer's disease will be determined by our ability to find the right genetic markers for early diagnosis and clinical intervention in patients at risk, as well as a greater understanding of the cellular and molecular processes that go wrong. After the National Institutes of Health (NIA) recognised urgent need to develop clinically useful neuroimaging and other biomarkers for the early detection of Alzheimer's disease, the Alzheimer's Disease Neuroimaging Initiative (ADNI) was established in 2004.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
